| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Pacific Biosciences of California, Inc.
13G/A
Amendment 5
PACB · 69404D108
|
2.8% |
11/14/2025
Event 9/30/2025
|
|||
| Madrone Capital Partners, LLC | 1.7% | ||||
| Madrone Opportunity Fund, L.P. | 1.7% | ||||
| Shimoda Holdings, LLC | 1.2% | ||||
| Gregory Boyd Penner | 2.8% | ||||
| Jameson J. McJunkin | 1.7% | ||||
| Thomas Patterson | 1.7% | ||||
|
Pacific Biosciences of California, Inc.
13G/A
Amendment 4
PACB · 69404D108
|
6.8% |
8/13/2025
Event 6/30/2025
|
|||
| Madrone Capital Partners, LLC | 5.6% | ||||
| Madrone Opportunity Fund, L.P. | 5.6% | ||||
| Shimoda Holdings, LLC | 1.2% | ||||
| Gregory Boyd Penner | 6.8% | ||||
| Jameson J. McJunkin | 5.6% | ||||
| Thomas Patterson | 5.6% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.